Skip to content

Effects of Therapeutic Touch in Patients With Female Genital Neoplasia: a Randomized Controlled Clinical Trial

Effects of Therapeutic Touch in Patients With Female Genital Neoplasia: a Randomized Controlled Clinical Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03142477
Enrollment
90
Registered
2017-05-05
Start date
2016-08-01
Completion date
2018-12-31
Last updated
2017-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gynecologic Cancer, Gynecologic Neoplasm, Palliative Care, Quality of Life, Reiki, Therapeutic Touch

Keywords

Therapeutic touch, Reiki, Laying-on-of-Hands, Spiritual Therapies

Brief summary

This is a randomized controlled prospective study on the use of therapeutic touch in patients diagnosed with gynecological cancer. The patients will be randomized into three groups: control group (will not receive any interventions with therapeutic touch), placebo group (will receive simulated therapeutic touch intervention by individual not knowing this technique) and treatment group(will receive therapeutic touch intervention by a trained therapeutic touch therapist). Two different quality of life questionnaires will be applied (before and after treatment). Levels of cortisol, salivary IgA, hematological indices and telomerase activity before and after the use of therapeutic touch will be compared between groups.

Detailed description

This project is a randomized controlled prospective study on the use of therapeutic touch in patients diagnosed with gynecological cancer. The patients will be randomized into three groups: control group (will not receive any interventions with therapeutic touch), placebo group (will receive simulated therapeutic touch intervention by individual not knowing the practice) and treatment group (will receive therapeutic touch intervention by a trained therapeutic touch therapist). Two different quality of life questionnaires (World Health Organization quality of life questionnaire - WHOQOL-Bref and the quality of life Core-30 questionnaire - EORTC QLQ-C30) from the European Organization for Research and Treatment of Cancer will be applied before and after treatment. Levels of cortisol, salivary IgA, hematological indices and telomerase activity before and after the use of therapeutic touch will be compared between groups.

Interventions

OTHERQuestionnaires

Two different quality of life questionnaires (WHOQOL-Bref and EORTC QLQ-C30) will be applied before and after treatment. No true or placebo therapeutic touch intervention will be performed.

OTHERPlacebo therapeutic touch

Placebo therapeutic touch will be done by graduate students without any specific training. The students are instructed to perform the placebo therapeutic touch with no objective intention of improving the patient's health.

OTHERTherapeutic touch

Therapeutic touch will be done by therapeutic touch trained professionals graduate students without any specific training with the intention of improving the patient's health.

Sponsors

Federal University of Minas Gerais
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Patients will be randomized into tree different groups: control, placebo, treatment.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* female patients * age over 18 years * diagnosis of neoplasms of the female genitalia * Signature of the consent form

Exclusion criteria

* history of previous contact with the therapeutic touch technique * use of psychotropic drugs, severe neurological or psychiatric disorders that make it impossible to participate in the study.

Design outcomes

Primary

MeasureTime frameDescription
Quality of lifeup to 16 weeks of follow-upQuality of life questionnaire WHOQOL-Bref

Secondary

MeasureTime frameDescription
Salivary cortisolBetween 10 to 16 weeksSalivary cortisol will be measured after the use of therapeutic touch
Quality of life 2up to 16 weeks of follow-upQuality of life questionnaire EORTC QLQ-C30
Telomerase activityup to 16 weeks of follow-upTelomerase activity will be measured after the use of therapeutic touch

Countries

Brazil

Contacts

Primary ContactRubens Tavares, MD, PhD
rubens.ufmg@gmail.com5531 3409 9485
Backup ContactGelza Nunes, MSc
nunesgelza@gmail.com5531 3409 9485

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026